World Class Extractions Awarded U.S. Patent for Solvent Based Extraction Methods from Large-Scale Harvests of Cannabis and Hemp Crops

~ Issuance of U.S. Patent No. 10,946,306 covering methods for the efficient extraction and concentration of cannabinoids and other target compounds from large-scale harvests of cannabis and hemp crops, continuing to bolster World Class' intellectual patent portfolio
VANCOUVER, BC /  March 17, 2021 / World-Class Extractions Inc. (CSE:PUMP) (FRA:WCF) (OTCQB:WCEXF) (the "Company" or "World-Class") is pleased to announce the United States Patent and Trademark Office ("USPTO") has issued U.S. Patent No. 10,946,306 on March 16, 2021 in relation to the Company's methods for the systematic extraction and concentration of cannabinoids and other target compounds via solvent extraction from large scale harvests of cannabis and hemp crops. This is World-Class' second issued U.S. patent.
World-Class' patented plant processing technology allows for the solvent-based extraction of cannabinoids from virtually all types of cannabis plant materials, including hemp, derived from large-scale commercial farming operations. World-Class' patent process minimizes energy consumption, conserves the volume of solvent utilized in the extraction process, and maximizes the quantity of cannabinoids sought to be extracted on a large-scale, commercial basis, than other known cannabinoid extraction techniques.
Read more: World-Class Extractions ( PUMP )

Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product License for SmoothX; Radiographic Barium Contrast Suspension

Calgary, Alberta –  February 12, 2021 – Voyageur Pharmaceuticals Ltd. ( TSXV : VM ) USA (OTC : VYYRF) (the "Company" or "Voyageur") is pleased to announce that it has received approval from Health Canada for SmoothX.   SmoothX is a barium radiographic contrast suspension that is specifically formulated for computed tomography procedures (CT Scans).   This approval authorizes the sale of SmoothX for use in radiology procedures in Canada.   SmoothX is specifically designed for use on CT Scans of the abdomen and gastrointestinal tract in both adults and pediatric patients.
Voyageur has four additional barium radiographic contrast Products that are currently under review by Health Canada and we expect product licences to be forthcoming.  
“Voyageur’s business plan has always been to launch Barium Contrast Radiographic Suspension products into the Canadian marketplace initially, then pursue other markets. This approval is the critical milestone to allow our company to transition to a cash flowing pharmaceutical company” reports Brent Willis, Voyageur’s CEO.
Read more: Voyageur Pharmaceuticals ( VM )

World-Class Extractions Enters the Legal Recreational Market for Cannabis Extracts and Signs Joint Venture Agreement to Deploy Full Cannabis and Hemp Extraction & Processing Facility

TORONTO, ON /  September 25, 2019 / World-Class Extractions Inc. ("World-Class") (CSE:PUMP)(FRA:WCF) announces its first multi-year joint venture agreement (the "Joint Venture") with FV Pharma Inc. (HUGE) (FSDDF) (0K9), a wholly-owned subsidiary of FSD Pharma Inc. ("FSD"). Under the direction of FV Pharma, World-Class will setup and manage the operations of "Cobra", a large capacity extraction and processing facility in Cobourg, Ontario, owned by FSD Pharma (the "Facility") to extract various cannabinoids and other valuable elements from cannabis and hemp plants.
The Facility will be deployed in multiple phases to satisfy the increasing market demand as the legal recreational market for cannabis extracts and extract-based products rapidly approaches. World Class and FSD each have a 50% interest in the Joint Venture. The initial phase, which is scheduled to commence production in December 2019, is comprised of several BOSS CO2 Extraction Systems as well as WCE's BEAST Ethanol Extraction System, along with all the ancillary equipment required for the preparation of the biomass, as well as refining and distillation processes. With ample room to expand, the Facility will initially have an extraction and processing capacity of up 5,000 pounds of biomass per day. As market demand increases, additional equipment will be deployed to accommodate the extraction and processing of up to 75,000 pounds per day.
Read more: World-Class Extractions ( PUMP )

Cannabix Technologies Achieves THC Breath Capture Milestone, Comments on Patent Portfolio

VANCOUVER, British Columbia, July 24, 2019  -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company scientists have developed proprietary methods resulting in the achievement of the highest ∆9-tetrahydrocannabinol (“THC”) detection levels collected from human breath to date. Over the last several months, Company scientists have studied the unique chemical interactions of THC and cannabinoids in breath, and developed and evaluated novel methods to efficiently and practically capture and ionize THC and cannabinoid analytes collected from several different subjects. These analytes are typically found in extremely low quantities due to their relatively low volatilities, requiring an efficient sampling method.  The Company’s newly developed methods and technologies for sample capture are an important milestone and represent a significant advancement in the field of human breath studies. These novel capture methods could have implications for both point-of-care and lab-based instruments that would provide real-time results from breath samples, targeting analytes of a wide range of volatilities. The Company continues to expeditiously conduct trial testing to evaluate the sensitivity and accuracy of the instrument and to collect data to determine variance among test subjects at its Vancouver and Florida development facilities using its FAIMS (field asymmetric waveform ion mobility spectrometry) THC detection device.
Read more: Cannabix Technologies ( BLO )

World Class and Quadron Announce Closing of Plan of Arrangement

Also News Release (C-QCC) Quadron Cannatech Corp
TORONTO and VANCOUVER, British Columbia, June 17, 2019  -- World Class Extractions Inc. (“World Class”) (CSE: PUMP) and Quadron Cannatech Corporation (“Quadron”) (CSE: QCC) are pleased to announce that that they have completed their previously announced plan of arrangement (the “Arrangement”) under the provisions of the Business Corporations Act (British Columbia), pursuant to which World Class has acquired all of the common shares of Quadron (the “Quadron Shares”) following Quadron’s amalgamation with World Class’s wholly-owned subsidiary, 1212476 B.C. LTD., to form a new wholly-owned subsidiary of World Class continuing as “Quadron Cannatech Corporation” (“Amalco”).
“The merger of Quadron Cannatech with World Class Extractions accelerates the pace and effectively increases progress towards our strategic goals of becoming the world’s largest extraction company in terms of capacity,” said Rosy Mondin, the new Chief Executive Officer of World Class. “The reconstituted management and board have diverse and strategically-relevant backgrounds to address the global opportunities arising in the cannabis and hemp industries.”
Read more: World Class Extractions ( PUMP )